A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL

Mark R. Wills, A.J. Carmichael, Kim Mynard et al. · Journal of Virology · 1996 · 690 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Rapid Effector Function in CD8+ Memory T Cells

Ajit Lalvani, Roger H. Brookes, Sophie Hambleton et al. · The Journal of Experimental Medicine · 1997 · 642 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

Cécil Czerkinsky, Gudrun Andersson, Hans-Peter T. Ekre et al. · Journal of Immunological Methods · 1988 · 496 citations

Life Sciences, Immunology, Molecular Biology +12

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

Keith L. Knutson, Kathy Schiffman, Mary L. Disis · Journal of Clinical Investigation · 2001 · 450 citations · Full text

Life Sciences, Immunology, Oncology +17

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8⁺ virus‐specific cytotoxic T lymphocytes

E McLaughlin-Taylor, Hema Pande, Stephen J. Forman et al. · Journal of Medical Virology · 1994 · 346 citations

Life Sciences, Immunology, Infectious Diseases +16